Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ETON

Eton Pharmaceuticals, Inc.

Healthcare | Biotechnology

No licensed closing price on file for ETON. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$0.39

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 12:21 UTC.

What Eton Pharmaceuticals, Inc. does

Eton Pharmaceuticals is a company that develops and commercializes treatments for rare diseases. The company currently offers eight commercial products treating conditions such as severe primary insulin-like growth factor 1 deficiency, adrenocortical insufficiency, Wilson disease, phenylketonuria, and other rare metabolic and endocrine disorders. Eton has five additional product candidates in late-stage development across similar therapeutic areas.

Summarized from Eton Pharmaceuticals, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$0.39
Return on equity-17.59%
Debt/equity0.60

Revenue, margins & earnings

FY2021: net loss $2M on revenue $22M$22MFY2021FY2022: net loss $9M on revenue $21M$21MFY2022FY2023: net loss $936,000 on revenue $32M$32MFY2023FY2024: net loss $4M on revenue $39M$39MFY2024FY2025: net loss $5M on revenue $80M$80MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-06
  • 2026-10-06Chief Business OfficerOption exercise10,522—
  • 2026-10-06Chief Business OfficerRestricted Stock UnitsOption exercise-10,522—
  • 2026-10-06Chief Business OfficerSale-4,166$229.4K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Eton Pharmaceuticals, Inc. do?

Eton Pharmaceuticals is a company that develops and commercializes treatments for rare diseases.

When did ETON last file with the SEC?

Eton Pharmaceuticals, Inc.'s most recent SEC filing on record is a 8-K filed 2026-06-09. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 12:21 UTC. This page is also available as JSON at /api/data?ticker=ETON and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ETON and 5,000+ tickers.

Create a free account — keep ETON
For your agent
GET /api/data?ticker=ETON

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt